PMCPA Case
| Case number | AUTH/3285/12/19 |
|---|---|
| Case reference | Ex-employee v Daiichi-Sankyo |
| Complainant | Ex-employee |
| Respondent/company | Daiichi-Sankyo |
| Product(s) | Not stated |
| Material/channel | Disclosure UK (transfers of value disclosures) |
| Key issue | Omitted/underreported transfers of value for HCP sponsorship to attend conferences (including indirect ToVs via third parties) across 2016–2018; inadequate processes and record retention |
| Dates (received/completed if stated) | Complaint received: 30 November 2019; Undertaking received: 13 February 2020; Interim case report first published: 1 September 2020; Case completed: 23 February 2023 |
| Appeal | Complainant appealed the ruling of no breach of Clause 24.10; appeal unsuccessful and no breach upheld |
| Code year | 2019 Code (Panel considered the case under the 2019 Code; noted 2016 Code also applied to the time period) |
| Breaches/clauses | Breach: Clauses 2, 9.1, 22.5, 24.1, 24.4, 24.6, 24.7, 24.9; No breach: Clause 24.10 |
| Sanctions | Public reprimand; audit required; subsequent re-audits (September 2020 audit; re-audits May 2021, March 2022, November 2022); ultimately no further action required |
Download the full case report (PDF):
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.